GlassScriptPhysician profile
Harry Hoyen
NPI 1326140021
$330,161.75
in general payments reported to CMS, 2019-2025
31 companies · $20K in 2025
The $20K reported for 2025 was more than what 95% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52K · 2020: $29K · 2021: $56K · 2022: $57K · 2023: $38K · 2024: $78K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $63K · Consulting Fee: $57K · Honoraria: $7,521 · Food and Beverage: $4,644 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $62,962.80 |
| Consulting Fee | $57,072.50 |
| Honoraria | $7,521.00 |
| Food and Beverage | $4,643.65 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $106,076.83 | 2019-2025 | Axsos, Remotion, Variax |
| Synthes Gmbh | $88,257.94 | 2019-2025 | |
| Medartis INC. | $67,610.68 | 2019-2025 | Aptus |
| Medical Device Business Services, INC. | $22,326.23 | 2019-2025 | Va-Lcp |
| Medacta USA, INC. | $18,188.47 | 2019-2022 | |
| Axogen | $16,635.76 | 2019-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Rock Medical Orthopedics, INC. | $3,269.95 | 2020-2024 | |
| Lima USA, INC. | $1,854.55 | 2022 | |
| Arthrex, INC. | $1,787.74 | 2019-2020 | |
| Acumed LLC | $769.48 | 2020-2025 | Acumed, Acumed, Inframe Implant |
| Carbofix Orthopedics INC | $664.00 | 2023 | |
| Curonix LLC | $369.81 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Endo Pharmaceuticals INC. | $304.62 | 2019-2023 | Xiaflex |
| Endo USA, INC. | $263.29 | 2025 | Xiaflex |
| Smith+Nephew, INC. | $251.17 | 2021-2024 | Panta 2, Evos |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Checkpoint Surgical, INC | $199.57 | 2023-2025 | Checkpoint Stimulators |
| Biocircuit Technologies INC | $150.05 | 2025 | Nerve Tape |
| Next Science LLC | $148.04 | 2023-2025 | Xperience, Blastx, Surgx |
| Tulavi Therapeutics, INC. | $147.42 | 2025 | Allay Nerve Cap - Small Nerve Set |
| Polynovo North America LLC | $131.42 | 2023 | |
| Orthocell LTD | $130.88 | 2025 | Remplir |
| Carbofix Spine INC | $109.00 | 2023 | |
| Osteomed LLC | $103.68 | 2020 | |
| Skeletal Dynamics INC | $100.48 | 2025 | Ijs, Geminus, Implate |
| Extremity Medical | $92.59 | 2023 | Io Fix |
| Exactech, INC. | $90.58 | 2024 | |
| Synthes USA Products LLC | $54.23 | 2025 | Na |
| Medline Industries LP | $38.73 | 2019 | |
| Anika Therapeutics, INC. | $19.50 | 2022 | |
| Arthrosurface Incorporated | $15.06 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,235,410.41 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Hoyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.